Ethan A. Huff,
November 16, 2011
Much of the attention concerning the dangers of getting vaccinated for human papillomavirus (HPV) and cervical cancer has been focused on Merck & Co.’s Gardasil. But a recent report in the UK’sDaily Mailexplains that GlaxoSmithKline’s (GSK) Cervarix, a competing HPV vaccine, recently left an otherwise healthy girl in a “waking coma” where she is now unable to talk or walk, and sleeps 23 hours a day because of a complete lack of energy.
Lucy Hinks’ parents, Steve and Pauline, say their 13-year-old daughter used to be a straight-A student with an excellent school attendance record, and a penchant and adeptness for math. Everything changed, however, after Lucy received her third installment of the HPV vaccine Cervarix back in May, which has left her in a near-vegetative state and in need of 24-hour care and monitoring.
Beginning in September 2008, the UK Department of Health began a national vaccination program that included vaccinating young girls against HPV with Cervarix. All young girls in school are subjected to the shot unless their parents take the time to deliberately opt out of it — but just like in the US, most parents are pressured into accepting it for their daughters based on empty reassurances about its alleged safety.
“I was concerned about the potential side effects because Lucy had a severe reaction from the MMR vaccine. But I was reassured by the school nurse that side effects were extremely unlikely,” said Lucy’s mother Pauline to theDaily Mail. “We feel betrayed because, like most parents, we trust the health authorities with our children’s lives.”